Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 022153/0340 | |
| Pages: | 15 |
| | Recorded: | 01/26/2009 | | |
| Attorney Dkt #: | 065571-0067 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ONE OF THE INVENTORS WAS OMITTED FROM THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 021974 FRAME 0162. ASSIGNOR(S) HEREBY CONFIRMS THE INVENTORS WISH TO ASSIGN U.S. SERIAL NO. 12/296,739 TO ABBOTT GMBH CO. KG. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/26/2013
|
Application #:
|
12296739
|
Filing Dt:
|
12/18/2008
|
|
Publication #:
|
|
Pub Dt:
|
06/04/2009
| | | | |
|
Title:
|
ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
|
|
|
Assignee
|
|
|
|
|
| MAX- PLANCK-RING 2 |
| WIESBADEN, GERMANY 65205 |
|
|
Correspondence name and address
|
| |
LISA V. MUELLER, DYKEMA GOSSETT PLLC
|
| |
10 SOUTH WACKER DRIVE
|
| |
SUITE 2300
|
| |
CHICAGO, IL 60606
|
Search Results as of:
05/29/2024 03:30 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
